A benefit - cost analysis of two-dose measles immunization in Canada

被引:34
作者
Pelletier, L
Chung, P
Duclos, P
Manga, P
Scott, J
机构
[1] Ctr Dis Control, Bur Infect Dis, Lab Ctr Dis Control, Ottawa, ON, Canada
[2] Pran Manga & Associates, Ottawa, ON, Canada
关键词
measles; cost; analysis;
D O I
10.1016/S0264-410X(97)00281-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In 1992, because of the limitations of the one-dose measles immunization program, the National Advisory Committee on Immunization (NACI) recommended a two-dose measles immunization program to eliminate measles, More recently, NACI recommended also a special catch-up program to prevent predicted measles outbreaks and to achieve an earlier elimination of measles, The objective of this study was to complete a benefit-cost analysis of a two-dose immunization program with and without a mass catch-up compaign compared with the current one-dose program. The resulting benefit:cost ratios vary between 2.61:1 and 4.31:1 depending on the strategy used and the age of the children targeted. Given the parameters established for this analysis, the benefits of a second-dose vaccination program against measles far outweigh the costs of such a program under all scenarios, (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:989 / 996
页数:8
相关论文
共 24 条
[1]  
ACRES R, 1985, CAN MED ASSOC J, V132, P535
[2]  
[Anonymous], 1994, COST BENEFIT ANAL ME
[3]  
[Anonymous], VACCINES
[4]   THE RESURGENCE OF MEASLES IN THE UNITED-STATES, 1989-1990 [J].
ATKINSON, WL ;
ORENSTEIN, WA ;
KRUGMAN, S .
ANNUAL REVIEW OF MEDICINE, 1992, 43 :451-463
[5]  
*CDC, 1984, MUMPS SURV JAN 1977
[6]  
*CDCP, 1995, EP PREV VACC PREV DI
[7]  
DANIELS S, PHERO 2801, P2
[8]   A COST-EFFECTIVENESS ANALYSIS OF MEASLES OUTBREAK CONTROL STRATEGIES [J].
DAVIS, RM ;
MARKOWITZ, LE ;
PREBLUD, SR ;
ORENSTEIN, WA ;
HINMAN, AR .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1987, 126 (03) :450-459
[9]  
FEIGIN RD, 1992, TXB PEDIAT INFECT DI, V2
[10]   Modelling the incidence of measles in Canada: an assessment of the options for vaccination policy [J].
Gay, NJ ;
Pelletier, L ;
Duclos, P .
VACCINE, 1998, 16 (08) :794-801